Generic placeholder image

Current Pharmaceutical Design

Editor-in-Chief

ISSN (Print): 1381-6128
ISSN (Online): 1873-4286

Corrigendum

Corrigendum: N-unsubstituted Imidazoles: Design, Synthesis, and Antimicrobial Evaluation

Author(s): Asghar Davood*, Yassamin EbrahimiNassimi, Soroush Sardari and Yekta Farmahini Farahani

Volume 30, Issue 15, 2024

Published on: 19 April, 2024

Page: [1209 - 1209] Pages: 1

DOI: 10.2174/138161283015240420013314

Price: $65

Abstract

A typographical error appeared in author's affiliation in the article titled “N-unsubstituted Imidazoles: Design, Synthesis, and Antimicrobial Evaluation”, published in Current Pharmaceutical Design, 2023; 29(23): 1875-1881 [1].

Details of the error and a correction are provided below.

Original:

Author Affiliation: 1Department of Medicinal Chemistry, Faculty of Pharmaceutical Sciences, Tehran Islamic Azad Medical Sciences University, Tehran, Iran.

Corrected:

Author Affiliation: 1Department of Medicinal Chemistry, Faculty of Pharmaceutical Sciences, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran.

We regret the error and apologize to readers.

The original article can be found online at: https://www.eurekaselect.com/article/133413

Erratum For:
N-unsubstituted Imidazoles: Design, Synthesis, and Antimicrobial Evaluation

« Previous
[1]
Davood A. EbrahimiNassimi Y, Sardari S, Farahani YF. N-unsubstituted imidazoles: Design, synthesis, and antimicrobial evaluation. Curr Pharm Des 2023; 29(23): 1875-81.
[http://dx.doi.org/10.2174/1381612829666230807120704]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy